ArticleBMC cancer2025
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers.
Rima Saad Bouzid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it